$1.09
-0.04 (-3.54%)
Open$1.13
Previous Close$1.13
Day High$1.13
Day Low$1.08
52W High$4.59
52W Low$1.02
Volume—
Avg Volume4.94M
Market Cap2.78M
P/E Ratio—
EPS$-1.82
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,664.2% upside
Current
$1.09
$1.09
Target
$41.03
$41.03
$36.60
$41.03 avg
$68.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.5K | 54.5K | 1.35M |
| Net Income | -5,371,428 | -40,420,444 | -84,207 |
| Profit Margin | -83,520.0% | -79,344.0% | -6.2% |
| EBITDA | -5,425,561 | -43,096,011 | -111,401 |
| Free Cash Flow | — | — | -113,905 |
| Rev Growth | -88.0% | -88.0% | +20.4% |
| Debt/Equity | — | — | 1.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |